SALT LAKE CITY–(BUSINESS WIRE)–Clinical
Innovations, a member of Pritzker Group Private Capital’s family of
companies and the largest medical device company exclusively focused on
labor and delivery, today announced the appointment of Glenn Weatherley
as vice president and managing director of Clinical Innovations Europe.
As a certified biomedical scientist with nearly four decades of
international experience in the biomedical sciences and medical device
and diagnostic industries, Weatherley brings a strong track record of
successfully driving growth and business development across several
medical markets, including surgery and women’s health. In his new role,
he is responsible for leading the Clinical Innovations Europe team and
strategy for its growing list of European distribution partners.
Most recently, Weatherley was vice president of international markets
for Insulet Corporation, overseeing marketing initiatives and
distribution operations for Europe and Canada. From 2008 to 2014, he was
vice president of sales for Hologic’s European diagnostic franchise,
driving annual revenues of nearly $120 million. Before that, he held
business development, sales management and clinical support positions
throughout the U.K., Ireland and the Netherlands with Cytyc Corporation,
a women’s clinical product manufacturer, and NeuroMedical Systems, a
healthcare technology company.
Before transitioning to medical device distribution and business
development, Weatherley spent 17 years in biomedical science
specializing in laboratory diagnostics and cellular pathology at Dryburn
Hospital Durham and Newcastle General Hospital.
Weatherley was a member of the prestigious International Academy of
Cytology and attended the University of Northumbria, where he earned a
Higher National Certificate in Biomedical Sciences.
“Glenn is a proven medical sales and distribution leader with an
extensive background in the biomedical sciences that truly fits with our
mission to improve the lives of mothers and their babies throughout the
world,” said Steve Cash, senior vice president of global sales for
Clinical Innovations. “His top-down understanding of the industry and
leadership in the European market is invaluable for our continued global
growth and ongoing research, development and manufacturing of
innovative, industry-changing medical devices.”
About Clinical Innovations
Clinical Innovations is the largest medical device company exclusively
focused on labor and delivery. Already a market leader in several
categories with products such as the Koala® Intrauterine Pressure
Catheter; Kiwi® Vacuum-Assisted Delivery System; ROM Plus® Rupture of
Membranes Test; traxi® Panniculus Retractor and ClearView
Uterine Manipulator. Clinical Innovations is expanding its
global presence while directly researching and developing
state-of-the-art technologies and innovative medical devices that
fulfill its mission of improving the lives of mothers and their babies
throughout the world. Clinical Innovations is a Pritzker Group company.
For more information, visit clinicalinnovations.com.
About Pritzker Group
Pritzker Group, led by Tony and J.B. Pritzker, has three principal
investment teams: Private Capital, which acquires and operates leading
North America-based companies; Venture Capital, which provides
early-stage and growth venture funding to technology companies
throughout the United States; and Asset Management, which partners with
top-performing investment managers across global public markets.
Pritzker Group Private Capital acquires North America-based
middle-market companies with leading positions in the manufactured
products, services and healthcare sectors. The firm’s permanent,
proprietary capital base allows for efficient decision making, broad
flexibility with transaction structure and investment horizon, and
alignment with management teams focused on creating long-term value.
Pritzker Group brings significant resources, expertise and credibility
in building businesses and is an ideal partner for entrepreneur- and
family-owned companies. For more information, visit pritzkergroup.com.
Martha Arendt, 312.629.9400